MG
QNTM

Michael Gelband’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Michael Gelband’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-266
Closed -$15K – 2544
2022
Q1 		$15K Buy
+266
New +$16.1K ﹤0.01% 2112

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Michael Gelband's QNTM Position: Q2 2022 in Review

Michael Gelband sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2022, closing a stake of 266 shares — an estimated $15K sold.

Michael Gelband first reported a position in QNTM in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 17 funds tracked by Wall St. Rank hold QNTM as of Q2 2022.

  • Michael Gelband reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q2 2022 after selling out during the quarter.
  • Michael Gelband sold 266 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2022, an estimated $15K.
  • Michael Gelband first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2022 and held it in 1 quarter.
  • Michael Gelband's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $15K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.